From ONI Medical Systems, Inc.;
MSK-Extreme™MRI system is a dedicated high field extremity imaging device, designed to provide orthopedic surgeons and other physicians with detailed diagnostic images of the foot, ankle, knee, hand, wrist and elbow, all with the clinical confidence and advantages derived from high field, whole body MRI units. The light weight (less than 650 kg) of the OrthOne System performs rapid patient studies, is easy to operate, has a patient friendly open environment and can be installed in a practice office or hospital, all at a cost similar to a low field extremity machine.
New features include a more powerful operating system that offers increased scan speed as well as a 160-mm knee coil with higher signal to noise ratio, and the option of a CD burner.

From Toshiba America Medical Systems Inc.;
the EXCELART is a superconducting whole body MRI system with a short wide-bore magnet, operating at 1.5 T. It features powerful high-speed gradients with a revolutionary gradient acoustic noise reduction system: Pianissimo. The dramatic reduction of gradient acoustic noise by Pianissimo greatly enhances patient comfort during exams. The standard array platform and a wide range of array coils ensure excellent images. A powerful 64-bit RISC-based computer system and newly developed array processor realize high productivity.

Manufactured by Esaote S.p.A.;
a low field open MRI scanner with permanent magnet for orthopedic use. The outstanding feature of this MRI system is a patient friendly design with 24 cm diameter, which allows the imaging of extremities and small body parts like shoulder MRI. The power consumption is around 1.3 kW and the needed minimum floor space is an area of 16 sq m.
At RSNA 2006 Hologic Inc. introduced a new dedicated extremity MRI scanner, the Opera. Manufactured by Esaote is the Opera a redesign of Esaote's 0.2 Tesla E-Scan XQ platform, which now enables complete imaging of all extremities, including hip and shoulder applications. 'Real-time positioning' reportedly speeds patient setup and reduces exam times.
Esaote North America and Hologic Inc are the U.S. distributors of this MRI device.

If a device is to be labeled MR Safe, the following information should be provided:
If a device is to be labeled MR Compatible, the following information should be provided:
Test Conditions:
The static magnetic field strength (Gauss (G) or Tesla (T)) to which the device was tested and demonstrated to be MRI 'safe', 'compatible', or 'intended for use in' should be related to typical machine ratings (e.g. 0.5 T, 1.5 T, 2.0 T, and shielded or unshielded magnet, etc).
The same conditions should be used for the spatial gradient (field strength per unit distance (i.e., G/cm)) in which the device was tested and demonstrated to be 'safe', 'compatible', or 'intended for use in'.
Also the RF transmitter power used during testing of the device, should be related to this typical machine ratings.

The company changed its name from Advanced Magnetics, Inc. to AMAG Pharmaceuticals, Inc. in July 2007.
AMAG Pharmaceuticals, Inc., a biopharmaceutical company, developed and manufactured organ-specific diagnostic contrast agents that provide clearer images during magnetic resonance imaging (MRI) tests used to detect tumors and other abnormalities.
The company had two MRI related products on the market: Feridex I.V. (for the diagnosis of liver lesions) and GastroMARK (used for bowel and abdominal MR imaging). In November 2008, AMAG Pharmaceuticals, Inc. decided to discontinue the manufacturing of Feridex. The development of Combidex as a contrast agent for lymph disease has also been stopped.
The Company has now two commercial products: Feraheme® and GastroMARK®. Feraheme® is the trade name of Ferumoxytol (formerly Code 7228) and is indicated for the treatment of iron deficiency anemia. Feraheme® is also being developed as a diagnostic agent for vascular-enhanced magnetic resonance imaging (MRI) to assess peripheral arterial disease.

MRI Contrast Agents: